Sercloremine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sercloremine
Sercloremine.svg
Identifiers
CAS number 54403-19-9 YesY
PubChem 162749
ChemSpider 142884
Jmol-3D images Image 1
Properties
Molecular formula C14H16ClNO
Molar mass 249.74 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Sercloremine, usually as a hydrochloride, is an experimental drug candidate under study as an antidepressant.[1] This drug was developed by Novartis and is in Phase II clinical trials.[2]

References[edit]

  1. ^ US Patent 4600719 - Tetrahydropyridine and piperidine derivatives
  2. ^ "Chemdrug data page" (in Chinese, and English). Chemdrug. Retrieved July 29, 2011.